Effect of sparteine sulphate upon basal and nutrient-induced insulin and glucagon secretion in normal man.
Infusion of a therapeutic dose of sparteine sulphate, increased the basal plasma insulin level and lowered plasma glucose. When an intravenous glucose tolerance test was performed with the infusion, the total insulin AUC was significantly larger than in absence of sparteine (2025 vs 1464 microU/ml X min), plasma glucose levels were lower and improved glucose utilization was observed (kg:1.55 vs 1.39%). In the presence of arginine, sparteine sulphate stimulated both beta and alpha cells, increasing both the total insulin (1907 vs 1516 microU/ml X min p less than 0.02) and total glucagon AUCs (7616 +/- 654 vs 6789 +/- 707 pg/ml X min p less than 0.01). Thus, sparteine sulphate increased both basal and nutrient-induced insulin and glucagon secretion in normal man.
Sgambato
S
S
Paolisso
G
G
Passariello
N
N
Varricchio
M
M
D'Onofrio
F
F
D000328:Adult; D001120:Arginine / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D004435:Eating; D005934:Glucagon / Q000378:metabolism*; D006801:Humans; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000378:metabolism*; D008297:Male; D011188:Potassium / Q000378:metabolism; D013034:Sparteine / Q000494:pharmacology*; D013268:Stimulation, Chemical
D007328:Insulin; D013034:Sparteine; D005934:Glucagon; D001120:Arginine; D011188:Potassium; D002118:Calcium